Blog

Refractory Crohn Disease: No Benefit From Stem Cell Transplant – Medscape


Medscape

Refractory Crohn Disease: No Benefit From Stem Cell Transplant
Medscape
Compared with conventional treatment, stem cell transplant in patients with refractory Crohn disease does not improve sustained disease remission at 1 year and may cause significant toxicity, according to a study published in the December 15 issue of JAMA.
Hematopoietic stem cell transplantation does not provide improvement for News-Medical.net


Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn Disease JAMA: The Journal of the American Medical Association

all 3 news articles »

2015-12-16
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.